Followers | 0 |
Posts | 2177 |
Boards Moderated | 0 |
Alias Born | 04/13/2018 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, January 15, 2022 4:51:42 PM
Here is a quick run down on this Penny Stock scam company CYDY.
1. Corrupt CEO.
Nader "The Chipped Tooth Liar" Pourhassan was recently rebuked by the Delaware Courts for his "unmitigated greed" in a suit brought by angry investors regarding his ridiculous compensation awards despite poor performance. But that's merely the tip of the iceberg for this man, or Federal Inmate 54850-053 as he is better known.
Nader has a long criminal history ranging from bank fraud, domestic violence, unjust enrichment, art fraud. In each of these instances he had a certain Modus Operandi, "Rules For Thee, But Not For Me." Nader's toxic mix of ego, incompetence, and mental imbalances creates the worst of career criminals.
Recently his actions have gained the attention of the DOJ and SEC. The last two 10Qs reported by the company show a deepening investigation into him and the officers of the company. The investigation has also expanded into all potential clinical applications of the company's one drug Leronlimab.
2. Massive Exponential Debt.
CYDY currently owes over 600 billion in debt, with a market cap of just about 1 billion, the company is well underwater. The debt is broken down into toxic financing, promises to warrant holders, debt owed to companies like Aramex for services rendered. Of course there is also the generous compensation packages for the executives, and the money paid out for promotional services. Currently there is no revenue and none of the applications for the drug have been approved due to a lack of solid clinical results, or in the case of HIV an intentionally complete BLA.
That's right, Nader "The Chipped Tooth Liar" Pourhassan told Amarex to file an incomplete BLA. Why? In his own words in a email seized in discovery at the Amarex trial "it was to stop the share price from failling."
3. Low Share Price And Way Too Many Shares.
CYDY still has yet to dump 200,000,000 million shares on the market, or for that dump to be priced in. Current share price is .69. The math is grim and means CYDY won't be able to cover debts. In effect CYDY has created an Iron Ceiling preventing the share price from rising.
4. Zero Clinical Success For COVID.
Read the PRs and compare it to the clinical results.
5. Stock Scam Cult.
Visit any of the Reddit Subreddits about CYDY and be prepared to see conspiracy theories rivaling anti-vaxxer lies, Trump election fraud claims, and Bigfoot sightings. You can't make up the utter insanity there. These are the people that digitally attacked the FDA prompting a stern repsonse.
In the end CYDY is the grave of hubris.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM